表紙
市場調査レポート

米国の輸血診断市場

The US Blood Transfusion Diagnostics Market

発行 Frost & Sullivan 商品コード 325793
出版日 ページ情報 英文 113 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
米国の輸血診断市場 The US Blood Transfusion Diagnostics Market
出版日: 2015年03月10日 ページ情報: 英文 113 Pages
概要

当レポートでは、血液ドナーサンプルで実施される診断検査について調査し、区分別の分析、ドナー血清検査、血液型判定、および分子検査の検査数・価格の分析、市場予測、サプライヤーの市場シェア、製品分析、および新しい市場機会などをまとめ、お届け致します。

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場背景
  • 市場背景:血液バンクアナライザーの種類
  • 免疫血液学手法の比較
  • 顧客の声:輸血ラボの装置購入に影響を及ぼす要因
  • 顧客の声
  • 市場区分
  • 調達プロセス
  • 将来の医療トレンドの定義

第3章 競合プレイブック

  • 新たな市場機会

第4章 促進因子・阻害因子・動向:総輸血診断市場

  • 促進因子
  • 阻害因子
  • 上位6つの動向の市場影響

第5章 予測・動向:総輸血診断市場

  • 測定
  • 市場予測の影響要因
  • 収益予測
  • 収益予測の議論

第6章 血液型判定区分の分析

  • 収益予測
  • 収益予測の議論
  • ABO、Rh、RBC抗原型、抗体特定、およびスクリーニングの検査数
  • ABO、Rh、およびRBC抗原型の医療費
  • 血液型判定検査の検査数・価格分析
  • 抗体スクリーニング、特定、およびクロスマッチングのMedicare費用

第7章 疾病スクリーニング区分の分析

  • 収益予測
  • 血清・分子の収益予測
  • 収益予測の議論
  • 疾病スクリーニング・NAT試験の試験数・価格分析
  • 血清ドナー検査の検査数
  • 血清・NAT検査、1件当たりのコスト比較
  • 最も頻繁に注文される血液検査:ランク別

第8章 公認輸血センター

  • 公認の免疫血液学関連ラボ
  • 輸血センター

第9章 血液バンクサプライチェーンの概要

  • 血液バンクにおけるサプライチェーンの概要
  • 問題の領域・ソリューション

第10章 競合環境

  • 市場シェア
  • 市場シェア分析
  • 製品分析:血液型判定
  • 製品分析:疾病スクリーニング (血清・分子)
  • 製品分析:疾病スクリーニング (分子アッセイ)
  • 吸収、合併、および提携の評価

第11章 企業プロファイル

  • Immucor
  • Ortho Clinical Diagnostics
  • Beckman Coulter (Danaher)
  • BioRad

第12章 主な注目企業

  • Quotient Limited (previously known as Alba Bioscience)
  • Immucor
  • Diagast
  • 3Ti (Transfusion & Transplantation Technologies)

第13章 結論

第14章 付録

目次
Product Code: NE4E-52

Effective Strategies for Vendors to Tackle the Decrease in Blood Supply Demand

This research study focuses on diagnostic tests performed on blood donor samples. The market segments are divided by blood grouping and disease screening and cover manual and automated instruments as well as reagents used for Abo and Rh testing, RBC antigen, and antibody identification and detection. Disease screening includes both serological and molecular testing. Comprehensive reports on test volume and pricing analysis for donor serological tests, blood grouping, and molecular tests are provided. The market forecasts begin in 2015 and end in 2018 using a base year of 2014. Supplier market shares, extensive product analysis, and new market opportunities to tackle the decreasing demand for blood supply are discussed.

Key Questions This Study Will Answer

  • How is innovation changing the donor disease screening and blood grouping landscape?
  • Are the products/services offered today meeting customer needs or is additional development needed?
  • Will these products/services continue to exist, or will other companies acquire them?
  • Are the vendors in the space ready to go it alone, or do they need partnerships to take their businesses to the next level?
  • What was the trend in price for blood grouping and typing in 2012 and 2013? Has it increased or decreased?
  • What was the trends in price for disease screening tests in 2012 and 2013? Has it increased or decreased?

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Scope and Segmentation
  • 4. Market Segmentation
  • 5. Key Questions This Study Will Answer
  • 6. Measurements
  • 7. CEO's Perspective
  • 8. Key Companies to Watch
  • 9. Key Companies to Watch (continued)
  • 10. Executive Summary-2 Big Predictions
  • 11. Executive Summary-2 Big Predictions (continued)
  • 12. Executive Summary-2 Big Predictions (continued)

2. MARKET OVERVIEW

Market Overview

  • 1. Market Background
  • 2. Market Background-Types of Blood Bank Analyzers
  • 3. Market Background-Types of Blood Bank Analyzers (continued)
  • 4. Market Background-Types of Blood Bank Analyzers (continued)
  • 5. Comparison of Immunohematology Methods
  • 6. Voice of Customer-Factors Governing Equipment Purchase for a Transfusion Laboratory
  • 7. Voice of Customer
  • 8. Market Segmentation
  • 9. Procurement Process
  • 10. Defining Future Healthcare Trends

3. COMPETITIVE PLAYBOOK

Competitive Playbook

  • 1. New Market Opportunities
  • 2. New Market Opportunities (continued)

4. DRIVERS, RESTRAINTS, AND TRENDS-TOTAL BLOOD TRANSFUSION DIAGNOSTICS MARKET

Drivers, Restraints, and Trends-Total Blood Transfusion Diagnostics Market

  • 1. Market Drivers
  • 2. Market Restraints
  • 3. Market Impact of Top 6 Trends

5. FORECASTS AND TRENDS-TOTAL BLOOD TRANSFUSION DIAGNOSTICS MARKET

Forecasts and Trends-Total Blood Transfusion Diagnostics Market

  • 1. Measurements
  • 2. Measurements (continued)
  • 3. Factors Impacting Market Forecasts
  • 4. Revenue Forecast
  • 5. Revenue Forecast Discussion

6. BLOOD GROUPING SEGMENT ANALYSIS

Blood Grouping Segment Analysis

  • 1. Revenue Forecast
  • 2. Revenue Forecast Discussion
  • 3. Revenue Forecast Discussion (continued)
  • 4. Test Volume for Abo, Rh, RBC Antigen Typing, Antibody Identification, and Screening
  • 5. Medicare Expenditure for Abo, Rh, and RBC Antigen Typing
  • 6. Test Volume and Pricing Analysis for Blood Grouping Tests
  • 7. Test Volume and Pricing Analysis for Blood Grouping Tests (continued)
  • 8. Medicare Expenditure for Antibody Screening, Identification, and Cross Matching

7. DISEASE SCREENING SEGMENT ANALYSIS

Disease Screening Segment Analysis

  • 1. Revenue Forecast
  • 2. Revenue Forecast for Serological and Molecular
  • 3. Revenue Forecast Discussion
  • 4. Revenue Forecast Discussion (continued)
  • 5. Test Volume and Pricing Analysis for Disease Screening and NAT Tests
  • 6. Test Volume Serological Donor Screening Tests
  • 7. Test Volume Serological Donor Screening Tests (continued)
  • 8. Cost Comparison per Test for Serological and NAT
  • 9. Most Frequently Ordered Blood Tests by Rank

8. ACCREDITED TRANSFUSION CENTERS

Accredited Transfusion Centers

  • 1. Accredited Immunohematology Reference Laboratories
  • 2. Accredited Immunohematology Reference Laboratories (continued)
  • 3. Accredited Immunohematology Reference Laboratories (continued)
  • 4. Accredited Immunohematology Reference Laboratories (continued)
  • 5. Accredited Immunohematology Reference Laboratories (continued)
  • 6. Blood Transfusion Centers

9. OVERVIEW OF BLOOD BANK SUPPLY CHAIN

Overview of Blood Bank Supply Chain

  • 1. Overview of Supply Chain in Blood Banks
  • 2. Overview of Supply Chain in Blood Banks (continued)
  • 3. Problem Areas and Solution

10. COMPETITIVE ENVIRONMENT

Competitive Environment

  • 1. Market Share
  • 2. Market Share Analysis
  • 3. Product Analysis Blood Grouping
  • 4. Product Analysis Blood Grouping (continued)
  • 5. Product Analysis Disease Screening (Serological and Molecular)
  • 6. Product Analysis Disease Screening (Molecular Assays)
  • 7. Merger, Acquisition, and Partnership Assessment
  • 8. Merger, Acquisition, and Partnership Assessment (continued)
  • 9. Merger, Acquisition, and Partnership Assessment (continued)
  • 10. Merger, Acquisition, and Partnership Assessment (continued)

11. COMPANY PROFILES

Company Profiles

  • 1. Immucor
  • 2. Ortho Clinical Diagnostics
  • 3. Beckman Coulter (Danaher)
  • 4. BioRad

12. KEY COMPANIES TO WATCH

Key Companies to Watch

  • 1. Quotient Limited (previously known as Alba Bioscience)
  • 2. Immucor
  • 3. Diagast
  • 4. 3Ti (Transfusion & Transplantation Technologies)

13. THE LAST WORD

The Last Word

  • 1. The Last Word-2 Big Predictions
  • 2. The Last Word-Discussion
  • 3. The Last Word-Discussion (continued)
  • 4. Legal Disclaimer

14. APPENDIX

Appendix

  • 1. Drivers Explained
  • 2. Drivers Explained (continued)
  • 3. Restraints Explained
  • 4. Restraints Explained (continued)
  • 5. Restraints Explained (continued)
  • 6. Restraints Explained (continued)
  • 7. Restraints Explained (continued)
  • 8. Additional Studies of Interest
  • 9. Additional Studies of Interest (continued)
  • 10. Methodology
  • 11. Learn More-Next Steps
  • 12. List of Exhibits
  • 13. List of Exhibits (continued)
  • 14. List of Exhibits (continued)
  • 15. List of Exhibits (continued)
Back to Top